|
MTMR10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.21311899098964E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.10690020985282E-10 |
| Normal-vs-Stage2 |
1.860270E-03 |
| Normal-vs-Stage3 |
3.08080227995333E-11 |
| Normal-vs-Stage4 |
1.76136882856781E-12 |
| Stage1-vs-Stage2 |
8.728100E-02 |
| Stage1-vs-Stage3 |
1.625010E-01 |
| Stage1-vs-Stage4 |
4.598500E-03 |
| Stage2-vs-Stage3 |
1.722160E-02 |
| Stage2-vs-Stage4 |
9.227700E-04 |
| Stage3-vs-Stage4 |
9.655900E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.56568116646849E-12 |
| Normal-vs-AfricanAmerican |
7.90019999999947E-05 |
| Normal-vs-Asian |
1.54299999999274E-07 |
| Caucasian-vs-AfricanAmerican |
5.659200E-01 |
| Caucasian-vs-Asian |
5.863400E-01 |
| AfricanAmerican-vs-Asian |
8.708600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.11519995857645E-09 |
| Normal-vs-Female |
8.14437406404522E-12 |
| Male-vs-Female |
9.861200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.18230003565145E-09 |
| Normal-vs-Age(41-60Yrs) |
1.10779996287391E-09 |
| Normal-vs-Age(61-80Yrs) |
1.63819957599287E-10 |
| Normal-vs-Age(81-100Yrs) |
1.234500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.291200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.768000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.184800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.709800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.054800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.957800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.09679999999946E-05 |
| Classical-VS-Follicular |
7.377700E-02 |
| Classical-VS-Other |
7.688200E-01 |
| Classical-VS-Normal |
1.46790357646864E-11 |
| Tall-VS-Follicular |
4.37570000000331E-06 |
| Tall-VS-Other |
2.363200E-01 |
| Tall-VS-Normal |
2.4980018054066E-14 |
| Follicular-VS-Other |
8.430400E-01 |
| Follicular-VS-Normal |
1.753380E-04 |
| Other-VS-Normal |
3.723800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.45440001445508E-09 |
| Normal-vs-N1 |
1.80629955437439E-10 |
| N0-vs-N1 |
3.621700E-02 |
|
|
